Teacher Retirement System of Texas’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.88M Sell
14,247
-1,823
-11% -$242K 0.01% 618
2025
Q4
$2.28M Sell
16,070
-9,483
-37% -$1.37M 0.01% 627
2025
Q3
$3.59M Sell
25,553
-2,161
-8% -$293K 0.01% 647
2025
Q2
$3.48M Buy
27,714
+14
+0.1% +$1.61K 0.01% 669
2025
Q1
$3.06M Sell
27,700
-3,112
-10% -$394K 0.01% 687
2024
Q4
$4.21M Buy
30,812
+3,974
+15% +$492K 0.02% 558
2024
Q3
$3.09M Buy
26,838
+4,028
+18% +$552K 0.01% 600
2024
Q2
$3.14M Buy
22,810
+470
+2% +$64.5K 0.02% 506
2024
Q1
$3.08M Sell
22,340
-497
-2% -$67.9K 0.02% 520
2023
Q4
$3.01M Sell
22,837
-2,990
-12% -$344K 0.02% 473
2023
Q3
$2.91M Buy
25,827
+439
+2% +$46.2K 0.02% 540
2023
Q2
$2.39M Buy
25,388
+2,894
+13% +$283K 0.02% 602
2023
Q1
$2.28M Buy
22,494
+3,528
+19% +$367K 0.02% 681
2022
Q4
$2.27M Buy
18,966
+5,269
+38% +$617K 0.02% 661
2022
Q3
$1.46M Sell
13,697
-873
-6% -$88.6K 0.01% 913
2022
Q2
$1.42M Sell
14,570
-5,135
-26% -$474K 0.01% 666
2022
Q1
$1.85M Buy
19,705
+1,189
+6% +$101K 0.01% 727
2021
Q4
$1.58M Sell
18,516
-5,334
-22% -$491K 0.01% 850
2021
Q3
$2.29M Buy
23,850
+4,172
+21% +$394K 0.01% 674
2021
Q2
$1.92M Buy
19,678
+1,132
+6% +$109K 0.01% 705
2021
Q1
$1.8M Buy
18,546
+1,402
+8% +$147K 0.01% 696
2020
Q4
$1.64M Sell
17,144
-54,966
-76% -$5.31M 0.01% 640
2020
Q3
$6.93M Buy
72,110
+13,736
+24% +$1.59M 0.04% 375
2020
Q2
$7.12M Buy
58,374
+16,818
+40% +$1.86M 0.06% 342
2020
Q1
$3.6M Buy
41,556
+8,317
+25% +$814K 0.04% 387
2019
Q4
$3.57M Buy
+33,239
New +$3.48M 0.03% 434
2018
Q4
Sell
-10,580
Closed -$1.3M 1019
2018
Q3
$1.3M Sell
10,580
-7,645
-42% -$867K 0.01% 590
2018
Q2
$1.79M Sell
18,225
-1,350
-7% -$121K 0.01% 606
2018
Q1
$1.62M Sell
19,575
-9,780
-33% -$826K 0.01% 640
2017
Q4
$2.28M Buy
29,355
+22,118
+306% +$1.51M 0.02% 661
2017
Q3
$443K Buy
7,237
+271
+4% +$14.3K ﹤0.01% 680
2017
Q2
$320K Buy
6,966
+57
+0.8% +$2.77K ﹤0.01% 699
2017
Q1
$299K Hold
6,909
﹤0.01% 725
2016
Q4
$267K Sell
6,909
-2,426
-26% -$110K ﹤0.01% 779
2016
Q3
$473K Sell
9,335
-2,346
-20% -$117K ﹤0.01% 733
2016
Q2
$531K Buy
11,681
+1,088
+10% +$50.1K ﹤0.01% 825
2016
Q1
$419K Buy
10,593
+2,344
+28% +$93K ﹤0.01% 881
2015
Q4
$467K Sell
8,249
-2,219
-21% -$113K ﹤0.01% 649
2015
Q3
$417K Buy
10,468
+7,193
+220% +$348K ﹤0.01% 859
2015
Q2
$156K Buy
3,275
+726
+28% +$30.8K ﹤0.01% 915
2015
Q1
$101K Buy
2,549
+249
+11% +$8.91K ﹤0.01% 1114
2014
Q4
$51K Sell
2,300
-352
-13% -$6.67K ﹤0.01% 1324
2014
Q3
$42K Buy
2,652
+23
+0.9% +$344 ﹤0.01% 1397
2014
Q2
$39K Sell
2,629
-178
-6% -$2.51K ﹤0.01% 1558
2014
Q1
$45K Buy
2,807
+304
+12% +$5.2K ﹤0.01% 1271
2013
Q4
$23K Sell
2,503
-5,866
-70% -$57.2K ﹤0.01% 1700
2013
Q3
$95K Buy
8,369
+3,840
+85% +$52.8K ﹤0.01% 1748
2013
Q2
$61K Buy
+4,529
New +$55.6K ﹤0.01% 1558

Other funds holding NBIX

Teacher Retirement System of Texas's NBIX Position: Q1 2026 in Review

Teacher Retirement System of Texas reduced its Neurocrine Biosciences (NBIX) stake by 11% in Q1 2026, selling an estimated $242K and leaving 14,247 shares worth $1.88M. The position accounts for 0.01% of the portfolio, ranked #618.

Teacher Retirement System of Texas first reported a position in NBIX in Q2 2013 and has held it in 48 quarters since. The position peaked at $7.12M in Q2 2020. 696 funds tracked by Wall St. Rank hold NBIX as of Q1 2026.

  • Teacher Retirement System of Texas held 14,247 shares of Neurocrine Biosciences worth $1.88M as of Q1 2026.
  • Teacher Retirement System of Texas sold 1,823 Neurocrine Biosciences shares in Q1 2026, an estimated $242K.
  • Neurocrine Biosciences made up 0.01% of Teacher Retirement System of Texas's portfolio in Q1 2026, its #618 holding.
  • Teacher Retirement System of Texas first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 48 quarters since.
  • Teacher Retirement System of Texas's Neurocrine Biosciences position peaked at $7.12M in Q2 2020.
  • 696 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q1 2026.

Based on Teacher Retirement System of Texas's 13F filing for Q1 2026, filed 30 Apr 2026.